戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tion and lower levels of cerebrospinal fluid homovanillic acid.
2 ephrine, 3-methoxy-4-hydroxyphenylgycol, and homovanillic acid.
3 ed with healthy control individuals, whereas homovanillic acid (17 studies; SMD, -0.26; 95% CI, -0.39
4 s well as regulated the dopamine metabolites homovanillic acid and dihydroxyphenylacetic acid.
5 of tetrahydrobiopterin (BH4), neopterin, and homovanillic acid and low levels of tyrosine hydroxylase
6 30, 1994, were eligible for urinary assay of homovanillic acid and vanillylmandelic acid at 3 weeks a
7 ine metabolites (5-hydroxyindoleacetic acid, homovanillic acid, and 3-methoxy-4-hydroxyphenethylenegl
8 acetic acid, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 3-methoxytyramine in addition to
9  the metabolites 3,4-deoxyphenylacetic acid, homovanillic acid, and 5-hydroxyindoleacetic acid were m
10     Aspects of the interaction among thiols, homovanillic acid, and peroxidase are discussed which li
11 ebrospinal fluid 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan concentrations.
12 abolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, as found in the striatum.
13  CSF measures of 5-hydroxyindoleacetic acid, homovanillic acid, dehydroepiandrosterone, or pregnenolo
14                                          CSF homovanillic acid did not correlate with plasma total ch
15                                          The homovanillic acid : dopamine ratio, a metabolic index, i
16               The strongest ligands, such as homovanillic acid, eugenol, and methyl vanillate all con
17              Tissue levels of DA metabolites homovanillic acid (HVA) and 3,4-dihydroxyphenylacetic ac
18 binding potential (BP) with plasma levels of homovanillic acid (HVA) and clinical symptoms.
19 ns of dopamine, and the dopamine metabolites homovanillic acid (HVA) and dihydroxyphenylacetic acid (
20 , 3-4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) and in the DOPAC/dopamine ratio
21 uorescein molecules as the model analyte and Homovanillic acid (HVA) as the target bioanalyte within
22 3, 4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) by 76%, 53% and 40%, respectivel
23 s 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in caudate nucleus resulting fro
24            The average percentage of labeled homovanillic acid (HVA) in lumbar cerebrospinal fluid (C
25 kg i.p.) 15 min prior to sacrifice increased homovanillic acid (HVA) levels in the left medial prefro
26 of greater than 10 points and an increase in homovanillic acid (HVA) or 5-hydroxyindoleacetic acid (5
27                         CSF concentration of homovanillic acid (HVA) was significantly lower in the L
28            Levels of the dopamine metabolite homovanillic acid (HVA) were decreased in severely affec
29 SF concentrations of the dopamine metabolite homovanillic acid (HVA) were determined in 30 recently a
30 ne (DA), dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-H
31                                          CSF homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-H
32 triatal tissue punches were analyzed for DA, homovanillic acid (HVA), and DA activity (HVA/DA) using
33 sma levels of fenfluramine, norfenfluramine, homovanillic acid (HVA), cortisol, and prolactin were de
34 SF) concentration of the dopamine metabolite homovanillic acid (HVA), in an extended inbred vervet mo
35 ions of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), or 3-methoxy-4-hydroxyphenylgyc
36 , 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), were elevated over the same tim
37 , 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), were found to be decreased by >
38  the main metabolites, followed by DOPAC and homovanillic acid (HVA).
39 , 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA).
40 , 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA).
41 ites, 3,4-dihydroxyphenylalanine (DOPAC) and homovanillic acid (HVA); norepinephrine (NE) and its met
42  [3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA)] levels and tyrosine hydroxylase
43                                       Plasma homovanillic acid (HVA, a dopamine metabolite), adrenoco
44 ydroxyindoleacetic acid [5-HIAA]), dopamine (homovanillic acid [HVA]), and norepinephrine (3-methoxy-
45  of dopamine, 3,4-dihydroxybenzoic acid, and homovanillic acid in GSHPx knock-out mice than those see
46  or no response to L-dopa, and low levels of homovanillic acid in the central nervous system.
47 stored the decreased content of dopamine and homovanillic acid in the nigrostriatal neurons of the ag
48  metabolites, dihydroxyphenylacetic acid and homovanillic acid, increased in the auditory forebrain b
49       The CSF 5-hydroxyindoleacetic acid and homovanillic acid levels did not correlate significantly
50                                              Homovanillic acid levels in 16 (89%) of 18 patients and
51  3-methoxy-4-hydroxyphenylethyleneglycol and homovanillic acid levels in the treatment groups.
52  3-methoxy-4-hydroxyphenylethyleneglycol and homovanillic acid levels.
53 ograms and urinary vanillylmandelic acid and homovanillic acid measurements were performed during a 9
54 ystonia during treatment, growth hormone and homovanillic acid measures, psychotic symptom activation
55                                While neither homovanillic acid nor xanthine concentrations differenti
56 bolism to 3,4-dihydroxyphenylacetic acid and homovanillic acid, our results indicate that Met homozyg
57 f tyrosine-metabolizing bacteria to reducing homovanillic acid production, triggered neuroinflammatio
58           For controls, the mean [xanthine]/[homovanillic acid] quotient was 13.1+/-5.5 as compared t
59                              The [xanthine]/[homovanillic acid] ratio also increased between the firs
60                              The [xanthine]/[homovanillic acid] ratio in the Parkinson's disease subj
61  gamma-aminobutyric acid, 3-methoxytyramine, homovanillic acid, serotonin, histamine, amino acids, an
62 ds (PCLCs): vanillic acid, isovanillic acid, homovanillic acid, syringic acid, syringaldehyde, feruli
63 alyzed cerebrospinal fluid concentrations of homovanillic acid (the major catabolite of dopamine) and
64            All children had raised ratios of homovanillic acid to 5-hydroxyindoleacetic acid in cereb
65  catecholamine values, or an increase in the homovanillic acid to vanillylmandelic acid ratio greater
66                                              Homovanillic acid was found to be a suitable fluorogen i
67  of D-cycloserine, relevant amino acids, and homovanillic acid were assayed at baseline and at weeks
68 dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic acid were comparable in the young and aged